Tubercular Uveitis in the Event of HIV Infection about a Case

A. Traoré, H. Cissé, N. Tolo, D. Traoré, Condé Lassana, A. Kaya, A. Sanogo, B. Berthé, I. Dembélé, M. Saliou, D. Sy, N. Doumbia, S. M. Cissé, Boubacar Zana Cisse, M. Dembélé, A. Traoré, H. Traoré
{"title":"Tubercular Uveitis in the Event of HIV Infection about a Case","authors":"A. Traoré, H. Cissé, N. Tolo, D. Traoré, Condé Lassana, A. Kaya, A. Sanogo, B. Berthé, I. Dembélé, M. Saliou, D. Sy, N. Doumbia, S. M. Cissé, Boubacar Zana Cisse, M. Dembélé, A. Traoré, H. Traoré","doi":"10.4236/jtr.2019.74025","DOIUrl":null,"url":null,"abstract":"Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. This disease is the second leading cause of infectious mortality in the world after infection with the human immunodeficiency virus. We report a case of multifocal tuberculosis with neuromuscular and ocular localization in an HIV-1 immunosuppressed patient in clinical and virological failure following therapeutic discontinuation due to non-compliance. This is a 43-year-old immunocompromised HIV1 patient with a history of cerebral toxoplasmosis in 2016 who consulted for right hemiplegia. These symptoms would go back to about 3 days marked by a deficit of progressive installation of the right hemicorps preceded by diffuse headaches, of moderate intensity without triggering factor radiating to the eyes associated with an intermittent fever with periods of spontaneous remissions, night sweats and chills, non-selective anorexia, non-increasing physical asthenia and unquantified weight loss. Management was 8-month antituberculous treatment, combining the first two months isoniazid (INH), rifampicin (RMP), pyrazinamide (PZN) and ethambutol (EMB), then the next 6 months (INH) and rifampicin (RMP). The reintroduction of the same antiretroviral protocol and a reinforcement of the therapeutic education made it possible to observe a decrease of the viral load. Treatment of ocular involvement was instituted with Timosol 1 drop in the eyes morning and evening and Diclocid 1 mg/ml: 1 drop in the eyes in the morning.","PeriodicalId":70603,"journal":{"name":"结核病研究(英文)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"结核病研究(英文)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4236/jtr.2019.74025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. This disease is the second leading cause of infectious mortality in the world after infection with the human immunodeficiency virus. We report a case of multifocal tuberculosis with neuromuscular and ocular localization in an HIV-1 immunosuppressed patient in clinical and virological failure following therapeutic discontinuation due to non-compliance. This is a 43-year-old immunocompromised HIV1 patient with a history of cerebral toxoplasmosis in 2016 who consulted for right hemiplegia. These symptoms would go back to about 3 days marked by a deficit of progressive installation of the right hemicorps preceded by diffuse headaches, of moderate intensity without triggering factor radiating to the eyes associated with an intermittent fever with periods of spontaneous remissions, night sweats and chills, non-selective anorexia, non-increasing physical asthenia and unquantified weight loss. Management was 8-month antituberculous treatment, combining the first two months isoniazid (INH), rifampicin (RMP), pyrazinamide (PZN) and ethambutol (EMB), then the next 6 months (INH) and rifampicin (RMP). The reintroduction of the same antiretroviral protocol and a reinforcement of the therapeutic education made it possible to observe a decrease of the viral load. Treatment of ocular involvement was instituted with Timosol 1 drop in the eyes morning and evening and Diclocid 1 mg/ml: 1 drop in the eyes in the morning.
一例感染HIV的结核性葡萄膜炎
结核病是由结核分枝杆菌引起的一种传染病。这种疾病是世界上仅次于人类免疫缺陷病毒的第二大传染病死亡原因。我们报告了一例HIV-1免疫抑制患者的神经肌肉和眼部定位的多灶性肺结核,该患者因不合规而停止治疗后出现临床和病毒学失败。这是一名43岁的免疫缺陷HIV1患者,2016年有脑弓形虫病病史,因右侧偏瘫接受咨询。这些症状可以追溯到大约3天,其特征是右半体的渐进性安装不足,然后是弥漫性头痛,中等强度,没有触发因素辐射到眼睛,伴有间歇性发烧,伴有一段时间的自发缓解、盗汗和发冷、非选择性厌食症,不增加的体力衰弱和未量化的体重减轻。治疗为8个月的抗结核治疗,前两个月合并异烟肼(INH)、利福平(RMP)、吡嗪酰胺(PZN)和乙胺丁醇(EMB),随后6个月合并INH和利福平(RMP)。重新引入相同的抗逆转录病毒方案并加强治疗教育,使观察到病毒载量下降成为可能。眼部受累的治疗采用Timosol早晚各1滴,Diclocid 1 mg/ml:早上各1滴。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
150
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信